Paclitaxel and Carboplatin in Women With Malignant Mixed Mullerian Tumors (MMMT) of the Uterus
Condition(s):Mixed Tumor, MullerianLast Updated:May 9, 2016Completed
Hide Studies Not Open or Pending
Condition(s):Mixed Tumor, MullerianLast Updated:May 9, 2016Completed
Condition(s):Recurrent/Metastatic CarcinosarcomaLast Updated:February 4, 2022Unknown status
Condition(s):Ovarian Carcinosarcoma; Endometrial CarcinosarcomaLast Updated:July 6, 2023Active, not recruiting
Condition(s):Carcinosarcoma, Ovarian; Carcinosarcomas UterineLast Updated:August 25, 2021Completed
Condition(s):Carcinosarcoma, OvarianLast Updated:October 4, 2021Unknown status
Condition(s):Uterine CarcinosarcomaLast Updated:August 7, 2012Completed
Condition(s):Uterine Carcinosarcoma; Advanced Uterine CarcinosarcomaLast Updated:May 12, 2023Recruiting
Condition(s):Ovarian Carcinosarcoma; Uterine CarcinosarcomaLast Updated:February 8, 2024Recruiting
Condition(s):Carcinosarcoma of Ovary; Carcinosarcoma of Uterus; Carcinosarcoma of VaginaLast Updated:February 21, 2021Withdrawn
Condition(s):Mixed Mullerian Tumors of the UterusLast Updated:August 24, 2018Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.